These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 17032282

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A community-based study of Helicobacter pylori therapy using the strategy of test, treat, retest, and re-treat initial treatment failures.
    Lee YC, Wu HM, Chen TH, Liu TY, Chiu HM, Chang CC, Wang HP, Wu MS, Chiang H, Wu MC, Lin JT.
    Helicobacter; 2006 Oct; 11(5):418-24. PubMed ID: 16961802
    [Abstract] [Full Text] [Related]

  • 26. The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication.
    Akyildiz M, Akay S, Musoglu A, Tuncyurek M, Aydin A.
    Eur J Intern Med; 2009 Jan; 20(1):53-7. PubMed ID: 19237093
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.
    Marzio L, Coraggio D, Capodicasa S, Grossi L, Cappello G.
    Helicobacter; 2006 Aug; 11(4):237-42. PubMed ID: 16882326
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Comparison of rifabutin- and levofloxacin-based third-line rescue therapies for Helicobacter pylori].
    Jeong MH, Chung JW, Lee SJ, Ha M, Jeong SH, Na S, Na BS, Park SK, Kim YJ, Kwon KA, Ko KI, Jo Y, Hahm KB, Jung HY.
    Korean J Gastroenterol; 2012 Jun 25; 59(6):401-6. PubMed ID: 22735872
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Comparative study of the eradication of Helicobacter pylori: ranitidine bismuth citrate versus omeprazole plus two antibiotics for seven days].
    Bujanda L, Sánchez A, Iriondo C, Santos A, Cosme A, Muñoz C.
    An Med Interna; 2001 Jul 25; 18(7):361-3. PubMed ID: 11534420
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection.
    Fiorini G, Vakil N, Zullo A, Saracino IM, Castelli V, Ricci C, Zaccaro C, Gatta L, Vaira D.
    Clin Gastroenterol Hepatol; 2013 May 25; 11(5):507-10. PubMed ID: 23267869
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A, Kadayifci A, Safali M, Ilgan S, Bagci S.
    J Dig Dis; 2007 Nov 25; 8(4):211-5. PubMed ID: 17970879
    [Abstract] [Full Text] [Related]

  • 39. Randomized comparison of two non-bismuth-containing second-line rescue therapies for Helicobacter pylori.
    Chuah SK, Hsu PI, Chang KC, Chiu YC, Wu KL, Chou YP, Hu ML, Tai WC, Chiu KW, Chiou SS, Wu DC, Hu TH.
    Helicobacter; 2012 Jun 25; 17(3):216-23. PubMed ID: 22515360
    [Abstract] [Full Text] [Related]

  • 40. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH, Yeung CK, Lee KH.
    Aliment Pharmacol Ther; 2006 Jul 01; 24(1):81-6. PubMed ID: 16803605
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.